These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 2834218)
1. [Effect of diazepam on the specific binding of 3H-(D-Ala-2, D-Leu-5)-enkephalin by striatal membranes in the rat]. Beliaev NA; Petrichenko OB Farmakol Toksikol; 1988; 51(1):18-21. PubMed ID: 2834218 [TBL] [Abstract][Full Text] [Related]
2. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes. Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503 [TBL] [Abstract][Full Text] [Related]
3. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C. Werling LL; Zarr GD; Brown SR; Cox BM J Pharmacol Exp Ther; 1985 Jun; 233(3):722-8. PubMed ID: 2989494 [TBL] [Abstract][Full Text] [Related]
4. Naloxonazine effects on the interaction of enkephalin analogs with mu-1, mu and delta opioid binding sites in rat brain membranes. Cruciani RA; Lutz RA; Munson PJ; Rodbard D J Pharmacol Exp Ther; 1987 Jul; 242(1):15-20. PubMed ID: 3039108 [TBL] [Abstract][Full Text] [Related]
5. Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography. Morris BJ; Millan MJ; Herz A J Pharmacol Exp Ther; 1988 Nov; 247(2):729-36. PubMed ID: 2846828 [TBL] [Abstract][Full Text] [Related]
6. Biochemical characterization of high-affinity 3H-opioid binding. Further evidence for Mu1 sites. Nishimura SL; Recht LD; Pasternak GW Mol Pharmacol; 1984 Jan; 25(1):29-37. PubMed ID: 6323950 [TBL] [Abstract][Full Text] [Related]
7. Opiate receptor binding and behavioral effects of morphine in RHA/Verh and RLA/Verh rats. Lazega D; Driscoll P; Frischknecht HR; Siegfreid B; Waser PG NIDA Res Monogr; 1986; 75():485-8. PubMed ID: 2828996 [TBL] [Abstract][Full Text] [Related]
8. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes. Tam SW; Liu-Chen LY J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954 [TBL] [Abstract][Full Text] [Related]
9. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus. Meunier JC; Kouakou Y; Puget A; Moisand C Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437 [TBL] [Abstract][Full Text] [Related]
10. [Stability of opiate receptors of wet and lyophilized preparations of rat brain membranes]. Zaĭtsev SV; Kurochkin IN; Sergeeva MG; Varfolomeev SD Biokhimiia; 1984 Jul; 49(7):1127-33. PubMed ID: 6089917 [TBL] [Abstract][Full Text] [Related]
11. Ethanol retains its ability to modify endogenous opiate system in aged rats. Rossi F; Quirico N; Carillo C Riv Neurol; 1988; 58(3):127-30. PubMed ID: 2845562 [TBL] [Abstract][Full Text] [Related]
12. [3H]Ethylketocyclazocine binding to mouse brain membranes: evidence for a kappa opioid receptor type. Garzón J; Sánchez-Blázquez P; Lee NM J Pharmacol Exp Ther; 1984 Oct; 231(1):33-7. PubMed ID: 6092603 [TBL] [Abstract][Full Text] [Related]
13. [The nature of cation-binding groups in binding sites for [[3H]Tyr1, D-Ala2, D-Leu5]enkephalin]. Zaĭtsev SV; Porodenko NV; Varfolomeev SD Bioorg Khim; 1985 Feb; 11(2):153-61. PubMed ID: 2986652 [TBL] [Abstract][Full Text] [Related]
14. Opiate binding in calf thalamic membranes: a selective mu 1 binding assay. Clark JA; Houghten R; Pasternak GW Mol Pharmacol; 1988 Sep; 34(3):308-17. PubMed ID: 2901663 [TBL] [Abstract][Full Text] [Related]
15. Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures. Tortella FC; Robles L; Mosberg HI J Pharmacol Exp Ther; 1987 Feb; 240(2):571-7. PubMed ID: 3027318 [TBL] [Abstract][Full Text] [Related]
16. Sodium regulation of agonist binding at opioid receptors. II. Effects of sodium replacement on opioid binding in guinea pig cortical membranes. Werling LL; Brown SR; Puttfarcken P; Cox BM Mol Pharmacol; 1986 Aug; 30(2):90-5. PubMed ID: 3016504 [TBL] [Abstract][Full Text] [Related]
17. [The effect of di- and trivalent metal ions on the binding of [3H-Tyr1, D-Ala2, D-Leu5] enkephalin to opiate receptors from the rat brain]. Porodenko NV; Zaĭtsev SV; Varfolomeev SD Bioorg Khim; 1984 Jul; 10(7):902-11. PubMed ID: 6093821 [TBL] [Abstract][Full Text] [Related]
18. Behavioral effects of opioid peptides selective for mu or delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats. Locke KW; Holtzman SG J Pharmacol Exp Ther; 1986 Sep; 238(3):997-1003. PubMed ID: 3018231 [TBL] [Abstract][Full Text] [Related]
19. Cystamine-enkephalin dimer. Syntheses and biological activities of enkephalin analogs containing cystamine and cysteamine. Kondo M; Kodama H; Costa T; Shimohigashi Y Int J Pept Protein Res; 1986 Feb; 27(2):153-9. PubMed ID: 3009340 [TBL] [Abstract][Full Text] [Related]
20. Differentiating aspects of opioid receptor binding by [3H](-) (1R,5R,9R,2''S)-5,9-dimethyl-2-tetrahydrofurfuryl-2'-hydroxy-6,7- benzomorphan hydrochloride ([3H]Mr 2034), a drug preferentially acting on kappa-receptors. Ensinger HA Arzneimittelforschung; 1985; 35(1A):447-51. PubMed ID: 2985096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]